| Missing Links?: 3267 Citation Matrix | Historiographs | Glossary HistCite Guide About |
Nodes: 14097,
Authors: 26332,
Journals: 1403,
Outer References: 422819,
Words: 20343
Yearly output |
Document Type |
Language |
Institution |
Institution with Subdivision |
Country
Collection span: 1953 - 2006
| View: Overview | Sorted by year, source, volume, issue, page. |
Page 127 of 141: 1 | 101 111 [ 121 122 123 124 125 126 127 128 129 130 ] 131 141
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
|---|---|---|---|---|---|
| 12601 | 37 | 121 | 12601 2004 BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY 17 (4): 595-611 Bhalla K; List A Histone deacetylase inhibitors in myelodysplastic syndrome | 3 | 4 |
| 12602 | 1 | 46 | 12602 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 321 (2): 306-312 Gardner L; Patterson AM; Ashton BA; Stone MA; Middleton J The human Duffy antigen binds selected inflammatory but not homeostatic chemokines | 0 | 2 |
| 12603 | 1 | 46 | 12603 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 322 (2): 593-600 Imamura T; Yamamoto S; Ohgane J; Hattori N; Tanaka S; et al. Non-coding RNA directed DNA demethylation of Sphk1 CpG island | 0 | 12 |
| 12604 | 5 | 44 | 12604 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 323 (1): 185-191 Tanaka Y; Tsumoto K; Umetsu M; Nakanishi T; Yasutake Y; et al. Structural evidence for guanidine-protein side chain interactions: crystal structure of CutA from Pyrococcus horikoshii in 3 M guanidine hydrochloride | 0 | 1 |
| 12605 | 10 | 61 | 12605 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 324 (2): 860-867 Li H; Wu XX Histone deacetylase inhibitor, Trichostatin A, activates p21(WAF1/CIP1) expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells | 2 | 3 |
| 12606 | 6 | 21 | 12606 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 324 (3): 1116-1123 Riester D; Wegener D; Hildmann C; Schwienhorst A Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates | 0 | 3 |
| 12607 | 25 | 40 | 12607 2004 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 325 (3): 683-690 Glaser KB; Li J; Pease LJ; Staver MJ; Marcotte PA; et al. Differential protein acetylation induced by novel histone deacetylase inhibitors | 7 | 9 |
| 12608 | 5 | 42 | 12608 2004 BIOCHEMICAL PHARMACOLOGY 68 (4): 753-760 Vanhaecke T; Henkens T; Kass GEN; Rogiers V Effect of the histone deacetylase inhibitor trichostatin A on spontaneous apoptosis in various types of adult rat hepatocyte cultures | 1 | 2 |
| 12609 | 17 | 46 | 12609 2004 BIOCHEMICAL PHARMACOLOGY 68 (6): 1139-1144 McLaughlin F; La Thangue NB Histone deacetylase inhibitors open new doors in cancer therapy | 7 | 15 |
| 12610 | 5 | 37 | 12610 2004 BIOCHEMICAL PHARMACOLOGY 68 (6): 1215-1220 Varier RA; Swaminathan V; Balasubramanyam K; Kundu TK Implications of small molecule activators and inhibitors of histone acetyltransferases in chromatin therapy | 3 | 5 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 12611 | 5 | 74 | 12611 2004 BIOCHEMICAL PHARMACOLOGY 68 (6): 1231-1238 Demonte D; Quivy V; Colette Y; Van Lint C Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: implications for the development of therapeutic strategies | 0 | 2 |
| 12612 | 17 | 38 | 12612 2004 BIOCHEMICAL PHARMACOLOGY 68 (7): 1279-1288 de Ruijter AJM; Kemp S; Kramer G; Meinsma RJ; Kaufmann JO; et al. The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastorna cells | 3 | 6 |
| 12613 | 7 | 22 | 12613 2004 BIOCHEMICAL PHARMACOLOGY 68 (9): 1729-1738 Martirosyan AR; Rahim-Bata R; Freeman AB; Clarke CD; Howard RL; et al. Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model | 0 | 1 |
| 12614 | 12 | 35 | 12614 2004 BIOCHEMICAL SOCIETY TRANSACTIONS 32: 904-909 Marmorstein R Structure and chemistry of the Sir2 family of NAD(+)-dependent histone/protein deactylases | 1 | 3 |
| 12615 | 2 | 35 | 12615 2004 BIOCHEMICAL SOCIETY TRANSACTIONS 32: 910-912 Yoo CB; Cheng JC; Jones PA Zebularine: a new drug for epigenetic therapy | 2 | 14 |
| 12616 | 9 | 87 | 12616 2004 BIOCHEMISTRY 43 (32): 10547-10559 Cassano AG; Anderson VE; Harris ME Analysis of solvent nucleophile isotope effects: Evidence for concerted mechanisms and nucleophilic activation by metal coordination in nonenzymatic and ribozyme-catalyzed phosphodiester hydrolysis | 1 | 3 |
| 12617 | 13 | 37 | 12617 2004 BIOCHEMISTRY 43 (34): 11083-11091 Schultz BE; Misialek S; Wu JS; Tang J; Conn MT; et al. Kinetics and comparative reactivity of human class I and class IIb histone deacetylases | 1 | 3 |
| 12618 | 3 | 19 | 12618 2004 BIOCHEMISTRY 43 (46): 14517-14520 Mildvan AS Inverse thinking about double mutants of enzymes | 3 | 11 |
| 12619 | 25 | 47 | 12619 2004 BIOCONJUGATE CHEMISTRY 15 (2): 300-306 Liu Y; Chen GS; Chen Y; Ding F; Liu T; et al. Molecular binding behavior of pyridine-2,6-dicarboxamide-bridged bis(beta-cyclodextrin) with oligopeptides: Switchable molecular binding mode | 4 | 4 |
| 12620 | 29 | 52 | 12620 2004 BIOCONJUGATE CHEMISTRY 15 (6): 1236-1245 Liu Y; Zhao YL; Chen Y; Ding F; Chen GS Binding behavior of aliphatic oligopeptides by bridged and metallobridged bis(beta-cyclodextrin)s bearing an oxamido bis(2-benzoic) carboxyl linker | 1 | 1 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 12621 | 28 | 134 | 12621 2004 BIOINORGANIC CHEMISTRY AND APPLICATIONS 2 (3-4): 237-274 Agrawal YK; Bhatt H Calixarenes and their biomimetic applications | 0 | 0 |
| 12622 | 5 | 55 | 12622 2004 BIOMATERIALS: FROM MOLECULES TO ENGINEERED TISSUES 553: 123-138 Ulubayram K Molecularly imprinted polymers | 0 | 0 |
| 12623 | 12 | 32 | 12623 2004 BIOORGANIC & MEDICINAL CHEMISTRY 12 (6): 1351-1356 Jose B; Okamura S; Kato T; Nishino N; Sumida Y; et al. Toward an HDAC6 inhibitor: synthesis and conformational analysis of cyclic hexapeptide hydroxamic acid designed from alpha-tubulin sequence | 3 | 3 |
| 12624 | 7 | 25 | 12624 2004 BIOORGANIC & MEDICINAL CHEMISTRY 12 (12): 3277-3287 Liu L; Breslow R Polymeric and dendrimeric pyridoxal enzyme mimics | 3 | 3 |
| 12625 | 4 | 10 | 12625 2004 BIOORGANIC & MEDICINAL CHEMISTRY 12 (16): 4351-4360 Maeda T; Nagaoka Y; Kuwajima H; Seno C; Maruyama S; et al. Potent histone deacetylase inhibitors: N-hydroxybenzamides with antitumor activities | 2 | 2 |
| 12626 | 9 | 35 | 12626 2004 BIOORGANIC & MEDICINAL CHEMISTRY 12 (22): 5767-5775 Liu Y; Chen GS; Chen Y; Cao DX; Ge ZQ; et al. Inclusion complexes of paclitaxel and oligo(ethylenediamino) bridged bis(beta-cyclodextrin)s: solubilization and antitumor activity | 2 | 2 |
| 12627 | 11 | 29 | 12627 2004 BIOORGANIC & MEDICINAL CHEMISTRY 12 (22): 5777-5784 Nishino N; Jose B; Shinta R; Kato T; Komatsu Y; et al. Chlamydocin-hydroxamic acid analogues as histone deacetylase inhibitors | 0 | 0 |
| 12628 | 5 | 32 | 12628 2004 BIOORGANIC & MEDICINAL CHEMISTRY 12 (22): 5973-5982 Madhavaiah C; Parvez M; Verma S Catalytic transformations with copper-metalated diglycine conjugates | 0 | 3 |
| 12629 | 4 | 8 | 12629 2004 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14 (2): 449-453 Wu TYH; Hassig C; Wu YQ; Ding S; Schultz PG Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group | 13 | 14 |
| 12630 | 5 | 18 | 12630 2004 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14 (3): 707-711 Wang DF; Wiest O; Helquist P; Lan-Hargest HY; Wiech NL QSAR Studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids | 3 | 8 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 12631 | 8 | 19 | 12631 2004 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14 (3): 723-726 Tsutsumi H; Ikeda H; Mihara H; Ueno A Enantioselective ester hydrolysis catalyzed by beta-cyclodextrin conjugated with beta-hairpin peptides | 1 | 1 |
| 12632 | 15 | 42 | 12632 2004 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14 (6): 1559-1562 Chandrasekhar V; Deria P; Krishnan V; Athimoolam A; Singh S; et al. Metalated hybrid polymers as catalytic reagents for phosphate ester hydrolysis and plasmid modification | 2 | 2 |
| 12633 | 5 | 14 | 12633 2004 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14 (7): 1783-1786 Nakajima H; Sakabe Y; Ikeda H; Ueno A Cyclodextrin trimers as receptors for arranging ester and catalyst at optimized location to achieve enhancement of hydrolytic activity | 1 | 1 |
| 12634 | 8 | 36 | 12634 2004 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14 (8): 1901-1904 Liang F; Wang P; Zhou X; Li T; Li ZY; et al. Nickle(II) and cobalt(II) complexes of hydroxyl-substituted triazamacrocyclic ligand as potential antitumor agents | 1 | 5 |
| 12635 | 16 | 29 | 12635 2004 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14 (10): 2427-2431 Nishino N; Yoshikawa D; Watanabe LA; Kato T; Jose B; et al. Synthesis and histone deacetylase inhibitory activity of cyclic tetrapeptides containing a retrohydroxamate as zinc ligand | 6 | 5 |
| 12636 | 4 | 22 | 12636 2004 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14 (10): 2477-2481 Marson CM; Serradji N; Rioja AS; Gastaud SP; Alao JP; et al. Stereodefined and polyunsaturated inhibitors of histone deacetylase based on (2E,4E)-5-arylpenta-2,4-dienoic acid hydroxyamides | 3 | 3 |
| 12637 | 1 | 23 | 12637 2004 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14 (10): 2657-2660 Natarajan A; Moerke N; Fan YH; Chen H; Christ WJ; et al. Synthesis of fluorescein labeled 7-methylguanosinemonophosphate | 0 | 1 |
| 12638 | 16 | 30 | 12638 2004 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14 (12): 3313-3317 Suzuki T; Kouketsu A; Matsuura A; Kohara A; Ninomiya S; et al. Thiol-based SAHA analogues as potent histone deacetylase inhibitors | 7 | 7 |
| 12639 | 12 | 24 | 12639 2004 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 14 (21): 5343-5346 Jose B; Oniki Y; Kato T; Nishino N; Sumida Y; et al. Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones | 5 | 5 |
| 12640 | 21 | 145 | 12640 2004 BIOPOLYMERS 73 (1): 90-109 Bevilacqua PC; Brown TS; Nakano S; Yajima R Catalytic roles for proton transfer and protonation in ribozymes | 2 | 22 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 12641 | 5 | 42 | 12641 2004 BIOSENSORS & BIOELECTRONICS 19 (7): 763-770 Forrow NJ; Walters SJ Transition metal half-sandwich complexes as redox mediators to glucose oxidase | 0 | 3 |
| 12642 | 4 | 24 | 12642 2004 BIOSENSORS & BIOELECTRONICS 20 (6): 1068-1075 Meng ZH; Yamazaki T; Sode K A molecularly imprinted catalyst designed by a computational approach in catalysing a transesterification process | 0 | 1 |
| 12643 | 2 | 53 | 12643 2004 BLOOD 103 (4): 1454-1463 Chevallier N; Corcoran CM; Lennon C; Hyjek E; Chadburn A; et al. ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cefl lymphorna oncoprotein | 1 | 12 |
| 12644 | 10 | 61 | 12644 2004 BLOOD 103 (12): 4636-4643 Piekarz RL; Robey RW; Zhan ZR; Kayastha G; Sayah A; et al. T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance | 8 | 14 |
| 12645 | 16 | 35 | 12645 2004 BRITISH JOURNAL OF HAEMATOLOGY 125 (2): 156-161 Khan SB; Maududi T; Barton K; Ayers J; Alkan S Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma | 8 | 13 |
| 12646 | 2 | 15 | 12646 2004 BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN 77 (1): 101-102 Aihara J Incorrect NICS-based prediction on the aromaticity of the pentalene dication | 2 | 7 |
| 12647 | 4 | 35 | 12647 2004 BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN 77 (3): 569-574 Watanabe S; Kosaka N; Kondo S; Yano Y Flavin receptors. Effects of melamine derivatives bearing thiourea and thiouronium ion on the binding and reactivity of flavin mimics in chloroform | 0 | 0 |
| 12648 | 6 | 42 | 12648 2004 BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN 77 (6): 1187-1193 Kanosue Y; Kojima S; Hiraga Y; Ohkata K Relationship between the hydrophobicity of dipeptides and the Michaelis-Menten constant K. of their hydrolysis by carboxypeptidase-Y and carboxypeptidase-A | 0 | 1 |
| 12649 | 15 | 110 | 12649 2004 BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN 77 (11): 2071-2080 Itami K; Terakawa K; Yoshida J; Kajimoto O The carbon-silicon bond cleavage of organosilicon compounds in supercritical water | 0 | 0 |
| 12650 | 5 | 37 | 12650 2004 BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN 77 (12): 2179-2183 Aihara J Bond-length equalization and aromaticity in charged pi-systems | 1 | 2 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 12651 | 5 | 47 | 12651 2004 BULLETIN OF THE KOREAN CHEMICAL SOCIETY 25 (8): 1273-1276 Kim JJ; Park YD; Cho SD; Kim HK; Kang YJ; et al. Preparation of O-alkylhydroxamic acids using 2-acylpyridazin-3(2H)-ones in water | 0 | 0 |
| 12652 | 1 | 24 | 12652 2004 BUNSEKI KAGAKU 53 (8): 805-815 Ohrui H Development of highly potent chiral discrimination methods that have solved the intrinsic problem of the diastereomer method | 0 | 0 |
| 12653 | 8 | 70 | 12653 2004 CAHIERS DE PSYCHOLOGIE COGNITIVE-CURRENT PSYCHOLOGY OF COGNITION 22 (6): 607-634 Colombel F; Gilet AL; Corson Y Implicit mood congruent memory bias in dysphoria: Automatic and strategic activation | 0 | 0 |
| 12654 | 4 | 50 | 12654 2004 CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE 82 (7): 1230-1233 Surendra K; Krishnaveni NS; Rao KR A simple biomimetic protocol for the oxidation of alcohols with sodium hypochlorite in the presence of beta-cyclodextrin in water | 0 | 1 |
| 12655 | 6 | 30 | 12655 2004 CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE 82 (11): 1589-1596 Gosse TL; Poirier RA Exo selectivity and the effect of disubstitution in the Diels-Alder reactions of butadiene with 3,3-disubstituted cyclopropenes | 0 | 0 |
| 12656 | 46 | 100 | 12656 2004 CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE 82 (12): 1791-1805 Brown RS; Neverov AA; Tsang JSW; Gibson GTT; Montoya-Pelaez PJ 2004 Bader Award Lecture - Metal-ion-catalyzed acyl and phosphoryl transfer reactions to alcohols: La3+-promoted alcoholysis of activated amides, carboxylate esters, and neutral organophosphorus esters | 0 | 2 |
| 12657 | 2 | 116 | 12657 2004 CANCER 101 (5): 1214-1228 Rimer BK; Briss PA; Zeller PK; Chan ECY; Woolf SH Informed decision making: What is its role in cancer screening? | 1 | 13 |
| 12658 | 11 | 17 | 12658 2004 CANCER BIOLOGY & THERAPY 3 (8): 719-720 Acharya MR; Figg WD Histone deacetylase inhibitor enhances the anti-leukemic activity of an established nucleoside analogue | 1 | 1 |
| 12659 | 3 | 87 | 12659 2004 CANCER BIOLOGY & THERAPY 3 (9): 831-837 Di Croce L; Buschbeck M; Gutierrez A; Joval I; Morey L; et al. Altered epigenetic signals in human disease | 1 | 3 |
| 12660 | 6 | 77 | 12660 2004 CANCER BIOLOGY & THERAPY 3 (11): 1109-1120 Sangster-Guity N; Yu LM; McCormick P Molecular profiling of embryonal carcinoma cells following retinoic acid or histone deacetylase inhibitor treatment | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 12661 | 7 | 49 | 12661 2004 CANCER CELL 5 (5): 455-463 Zhu P; Martin E; Mengwasser J; Schlag P; Janssen KP; et al. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis | 9 | 23 |
| 12662 | 8 | 29 | 12662 2004 CANCER CHEMOTHERAPY AND PHARMACOLOGY 54 (1): 57-63 Lea MA; Shareef A; Sura M; desBordes C Induction of histone acetylation and inhibition of growth by phenyl alkanoic acids and structurally related molecules | 1 | 2 |
| 12663 | 9 | 25 | 12663 2004 CANCER CHEMOTHERAPY AND PHARMACOLOGY 54 (1): 85-88 Berg SL; Stone J; Xiao JJ; Chan KK; Nuchtern J; et al. Plasma and cerebrospinal fluid pharmacokinetics of depsipeptide (FR901228) in nonhuman primates | 0 | 1 |
| 12664 | 9 | 39 | 12664 2004 CANCER CHEMOTHERAPY AND PHARMACOLOGY 54 (5): 398-406 Palumbo C; Albonici L; Bei R; Bocci C; Scarpa S; et al. HMBA induces cell death and potentiates doxorubicin toxicity in malignant mesothelioma cells | 0 | 0 |
| 12665 | 7 | 43 | 12665 2004 CANCER CHEMOTHERAPY AND PHARMACOLOGY 54 (6): 537-545 Kang JH; Chen J; Zhang DW; Da WM; Ou YX Synergistic killing of human leukemia cells by antioxidants and trichostatin A | 2 | 2 |
| 12666 | 1 | 24 | 12666 2004 CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 13 (11): 1967S-1967S Giovannucci E Prostate cancer risk increase: A downside of too much calcium? | 0 | 0 |
| 12667 | 2 | 26 | 12667 2004 CANCER IMMUNOLOGY IMMUNOTHERAPY 53 (8): 748-754 Khan ANH; Magner WJ; Tomasi TB An epigenetically altered tumor cell vaccine | 2 | 5 |
| 12668 | 5 | 30 | 12668 2004 CANCER INVESTIGATION 22 (6): 886-896 Pauer LR; Olivares J; Cunningham C; Williams A; Grove W; et al. Phase I study of oral CI-994 in combination with carboplatin and paclitaxel in the treatment of patients with advanced solid tumors | 2 | 4 |
| 12669 | 3 | 26 | 12669 2004 CANCER LETTERS 206 (1): 43-50 Cuendet M; Gills JJ; Pezzuto JM Brusatol-induced HL-60 cell differentiation involves NF-kappa B activation | 0 | 1 |
| 12670 | 8 | 26 | 12670 2004 CANCER RESEARCH 64 (1): 316-321 Camphausen K; Burgan W; Cerra M; Oswald KA; Trepel JB; et al. Enhanced radiation-induced cell killing and prolongation of gamma H2AX foci expression by the histone deacetylase inhibitor MS-275 | 14 | 24 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 12671 | 12 | 41 | 12671 2004 CANCER RESEARCH 64 (2): 689-695 Atadja P; Gao L; Kwon P; Trogani N; Walker H; et al. Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824 | 20 | 25 |
| 12672 | 2 | 24 | 12672 2004 CANCER RESEARCH 64 (3): 825-829 Hofer MD; Kuefer R; Varambally S; Li HJ; Ma J; et al. The role of metastasis-associated protein 1 in prostate cancer progression | 0 | 13 |
| 12673 | 13 | 33 | 12673 2004 CANCER RESEARCH 64 (3): 1079-1086 Gurvich N; Tsygankova OM; Meinkoth JL; Kein PS Histone deacetylase is a target of valproic acid-mediated cellular differentiation | 12 | 31 |
| 12674 | 11 | 57 | 12674 2004 CANCER RESEARCH 64 (7): 2580-2589 Guo F; Sigua C; Tao JG; Bali P; George P; et al. Cotreatment with histone deacetylase inhibitor LAQ824 enhances apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells | 19 | 35 |
| 12675 | 13 | 79 | 12675 2004 CANCER RESEARCH 64 (7): 2590-2600 Maggio SC; Rosato RR; Kramer LB; Dai Y; Rahmani M; et al. The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells | 14 | 22 |
| 12676 | 1 | 71 | 12676 2004 CANCER RESEARCH 64 (12): 4137-4147 Halmos B; Basseres DS; Monti S; D'Alo F; Dayaram T; et al. A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer | 0 | 5 |
| 12677 | 7 | 48 | 12677 2004 CANCER RESEARCH 64 (16): 5767-5774 Myzak MC; Karplus PA; Chung FL; Dashwood RH A novel mechanism of chemoprotection by sulforaphane: Inhibition of histone deacetylase | 2 | 16 |
| 12678 | 13 | 21 | 12678 2004 CANCER RESEARCH 64 (23): 8778-8781 Hsi LC; Xi XP; Lotan R; Shureiqi I; Lippman SM The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells | 1 | 6 |
| 12679 | 23 | 90 | 12679 2004 CANCER TREATMENT REVIEWS 30 (5): 461-472 Somech R; Izraeli S; Simon AJ Histone deacetylase inhibitors - a new tool to treat cancer | 2 | 15 |
| 12680 | 4 | 17 | 12680 2004 CARBOHYDRATE RESEARCH 339 (7): 1361-1366 Carofiglio T; Cordioli M; Fornasier R; Jicsinszky L; Tonellato U Synthesis of 6(I)-amino-6(I)-deoxy-2(I-VII),3(I-VII)-tetradeca-O-methyl-cyclomaltoheptaose | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 12681 | 2 | 67 | 12681 2004 CARCINOGENESIS 25 (2): 169-178 Gebel S; Gerstmayer B; Bosio A; Haussmann HJ; Van Miert E; et al. Gene expression profiling in respiratory tissues from rats exposed to mainstream cigarette smoke | 0 | 10 |
| 12682 | 7 | 63 | 12682 2004 CARCINOGENESIS 25 (7): 1227-1236 Druesne N; Pagniez A; Mayeur C; Thomas M; Cherbuy C; et al. Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines | 2 | 10 |
| 12683 | 9 | 203 | 12683 2004 CATALYSIS REVIEWS-SCIENCE AND ENGINEERING 46 (3-4): 369-417 Corma A Attempts to fill the gap between enzymatic, homogeneous, and heterogeneous catalysis | 1 | 3 |
| 12684 | 14 | 22 | 12684 2004 CELL CYCLE 3 (5): 534-535 Marks PA The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA) | 4 | 7 |
| 12685 | 59 | 157 | 12685 2004 CELL CYCLE 3 (6): 779-788 Lindemann RK; Gabrielli B; Johnstone RW Histone-deacetylase inhibitors for the treatment of cancer | 8 | 12 |
| 12686 | 6 | 18 | 12686 2004 CELL CYCLE 3 (10): 1240-1242 Zhu P; Huber E; Kiefer F; Gottlicher M Specific and redundant functions of histone deacetylases in regulation of cell cycle and apoptosis | 2 | 4 |
| 12687 | 11 | 68 | 12687 2004 CELL DEATH AND DIFFERENTIATION 11: S193-S206 Inoue S; MacFarlane M; Harper N; Wheat LMC; Dyer MJS; et al. Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies | 3 | 8 |
| 12688 | 4 | 36 | 12688 2004 CELLULAR AND MOLECULAR LIFE SCIENCES 61 (15): 1935-1945 Fu WX; Gong SY; Qian XP; Li Y; Zhu ML; et al. Differential chemotactic potential of mouse platelet basic protein for thymocyte subsets | 1 | 1 |
| 12689 | 2 | 39 | 12689 2004 CELLULAR MICROBIOLOGY 6 (3): 225-233 Popov SG; Popova TG; Grene E; Klotz F; Cardwell J; et al. Systemic cytokine response in murine anthrax | 0 | 12 |
| 12690 | 18 | 24 | 12690 2004 CHEMBIOCHEM 5 (6): 868-871 Liu Y; Yang YW; Song Y; Zhang HY; Ding F; et al. Residue-and sequence-selective binding of nonaromatic dipeptides by bis(beta-cyclodextrin) with a functional tether | 4 | 5 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 12691 | 4 | 33 | 12691 2004 CHEMICAL COMMUNICATIONS (2): 172-173 Prudden AR; Lien NR; Telford JR An outer-sphere ligand for uranyl carbonate | 0 | 1 |
| 12692 | 2 | 15 | 12692 2004 CHEMICAL COMMUNICATIONS (2): 202-203 Larsen J; Rasmussen BS; Hazell RG; Skrydstrup T Preparation of a novel diphosphine-palladium macrocyclic complex possessing a molecular recognition site. Oxidative addition studies | 0 | 0 |
| 12693 | 6 | 13 | 12693 2004 CHEMICAL COMMUNICATIONS (4): 408-409 Sasaki K; Nakagawa H; Zhang XY; Sakurai S; Kano K; et al. Construction of porphyrin-cyclodextrin self-assembly with molecular wedge | 2 | 6 |
| 12694 | 1 | 29 | 12694 2004 CHEMICAL COMMUNICATIONS (4): 442-443 Carroll JB; Gray M; Cooke G; Rotello VM Proton transfer versus redox modulation in thiourea-phenanthrenequinone molecular and polymeric complexes | 0 | 1 |
| 12695 | 8 | 45 | 12695 2004 CHEMICAL COMMUNICATIONS (17): 1968-1969 Harrowven DC; Guy IL KF-silica as a stationary phase for the chromatographic removal of tin residues from organic compounds | 0 | 5 |
| 12696 | 12 | 32 | 12696 2004 CHEMICAL COMMUNICATIONS (18): 2060-2061 Omura K; Uchida T; Irie R; Katsuki T Design of a robust Ru(salen) complex: aziridination with improved turnover number using N-arylsulfonyl azides as precursors | 0 | 9 |
| 12697 | 6 | 20 | 12697 2004 CHEMICAL COMMUNICATIONS (19): 2226-2227 Gunning P; Benninston AC; Peacock RD A modular ditopic crown-shielded phosphate ion-pair receptor | 1 | 3 |
| 12698 | 4 | 20 | 12698 2004 CHEMICAL COMMUNICATIONS (20): 2266-2267 Liu Y; Wang H; Zhang HY; Liang P A metallo-capped polyrotaxane containing calix[4]arenes and cyclodextrins and its highly selective binding for Ca2+ | 0 | 3 |
| 12699 | 0 | 24 | 12699 2004 CHEMICAL COMMUNICATIONS (22): 2616-2617 Barluenga J; Marco-Arias M; Gonzalez-Bobes F; Ballesteros A; Gonzalez JM New reactions in water: metal-free conversion of alcohols and ketones into alpha-iodoketones | 1 | 5 |
| 12700 | 14 | 25 | 12700 2004 CHEMICAL COMMUNICATIONS (23): 2770-2771 Suzuki Y; Yamauchi K; Muramatsu K; Sato M First example of chiral N-heterocyclic carbenes as catalysts for kinetic resolution | 2 | 11 |
Page 127 of 141: 1 | 101 111 [ 121 122 123 124 125 126 127 128 129 130 ] 131 141
Generated by HistCite 2006.02.28